Date: 20 July 2022
To | To |
BSE Limited | National Stock Exchange of India Limited |
Phiroze Jeejeebhoy Towers | Exchange Plaza |
Dalal Street | Bandra Kurla Complex |
Mumbai- 400001 | Bandra (E) |
Mumbai-400051 | |
Security Code: 540596 | Symbol: ERIS |
SUBJECT: INTIMATION OF RESIGNATION OF INDEPENDENT DIRECTOR OF THE COMPANY
Dear Sir / Madam,
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulation") read with Para A of Part A of Schedule III of the Listing Regulations, we hereby inform that Mrs. Vijaya Sampath (DIN: 00641110) has tendered her resignation from the position of Independent Director of the Company with effect from 19 July 2022. The details required under Regulation 30 of the Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, are given as under.
Sr. No. | Disclosure Requirement | Details |
1. | Reason for change, i.e., resignation | To pave the way and enable the composition of |
the Board to become more diverse in terms of | ||
experience, skill, and domain knowledge. | ||
2. | Date of cessation | 19 July 2022 |
Further, the Company has received confirmation from Mrs. Vijaya Sampath that there are no other material reasons for her resignation other than those which are provided in the resignation letter dated 19 July 2022. The said resignation letter incorporating the aforesaid confirmation along with the names of the listed entities in which Mrs. Vijaya Sampath holds directorships, indicating the category of directorship and membership of board committees, are enclosed herewith.
For Eris Lifesciences Limited
_______________________
Milind Talegaonkar
Company Secretary and Compliance Officer Membership No: A26493
19 July 2022
VIJAYA SAMPATH
14/403, Heritage City, MG Road
Gurgaon 122002
To,
The Chairman and Board of Directors
Eris Lifesciences Limited
Ahmedabad
Dear Mr. Bakshi,
As discussed, and agreed, I submit my resignation from the Board of Directors of Eris Lifesciences Limited and request you to kindly accept the same with immediate effect. It has been my privilege to serve on the Board and some committees for over five years and it has been a rewarding experience to work with the other Board members and yourself at the helm.
The reason for my resignation is to pave the way and enable the composition of the Board to become more diverse in terms of experience, skill, and domain knowledge. I am confident that in the coming years, under your leadership, a strong management team, and the able guidance of a more diverse Board, the company will grow from strength to strength. I confirm that other than as stated herein, there is no other material reason for my resignation from the Board.
I request you to kindly arrange to forward the copy of this letter to the stock exchange and file the requisite forms with the RoC with a confirmation to me.
I thank you and each one of the Board members for their support and cooperation during my tenure and wish the company a very successful future.
With best wishes
VIJAYA SAMPATH
BOARD &COMMITTEES OF BOARD AS OF 30 June 2022
No | Name of | Committees | Appointment | Shareholding | Listed/ |
company | date | Unlisted | |||
1 | GVS Envicon | NIL | 01/04/2006 | 33,000shares of INR | Unlisted |
Technologies | 10/ each 31.3% | private co | |||
Private Limited | |||||
2 | Nabha Power | Board | 12/01/2015 | NIL | Debt |
Company Limited | Audit © | Reappointed on | securities | ||
CSR/NRC/RMC | 14/01/20 | listed | |||
3 | L&T MHI Power | Board | 21/01/2015 | NIL | Unlisted |
Boilers Private | NRC | Reappointed on | public co | ||
Limited | 22/01/20 | ||||
4 | L&T MHI Power | Board | 22/01/2015 | NIL | Unlisted |
Turbine Generators | NRC | Reappointed on | public co | ||
Private Limited | 22/01/20 | ||||
5 | Safari Industries | Board | 22/09/2014 | NIL | Listed |
(India) Limited | NRC | Reappointed on | |||
CSR | 5/8/20 | ||||
6 | Eris Lifesciences | Board | 03/02/17 | 2220 equity shares | Listed |
Limited | Audit © | 03/02/2017 | of INR 10/each | ||
NRC© | 26/05/2017 | 1180 shares | |||
Reappointed | @Rs.742.39/ on | ||||
13/8/21 | |||||
7 | Varroc Engineering | Board | 20 July 2017 | 703 equity shares of | Listed |
Limited | Audit | 6 Feb 2018 | INR 1/each at INR | ||
(listed on 6 July | NRC | 6 Feb 2018 | 967/share | ||
2018) | RMC© | 31 March 2021 | |||
8 | Craftsman | Board | 3 April 2018 | NIL | Listed |
Automation | Audit | ||||
Limited | NRC© | ||||
9 | Intellect Design | Board | 25/10/18 | 1400 | Listed |
Arena Limited | Audit | 2/05/19 | shares@671.96/on | ||
NRC | 2/05/19 | 13/8/21 | |||
10 | Ingersoll Rand India | Board | 27/03/19 | NIL | Listed |
Limited | Audit | ||||
11 | VA Tech Wabag | Board | 31/07/20 | NIL | Listed |
Limited | NRC © | 29/09/20 | |||
CSR© | |||||
Overseas | |||||
Investment | |||||
Audit | 19/07/21 |
Vijaya Sampath
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Eris Lifesciences Ltd. published this content on 20 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 July 2022 07:53:06 UTC.